Schroder Investment Management Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-277,515
| Closed | -$4.6M | – | 1239 |
|
|
2023
Q1 | $4.6M | Buy |
+277,515
| New | +$4.6M | 0.01% | 800 |
|
|
2021
Q2 | – | Sell |
-767,041
| Closed | -$3.54M | – | 1532 |
|
|
2021
Q1 | $3.54M | Sell |
767,041
-145,486
| -16% | -$671K | ﹤0.01% | 898 |
|
|
2020
Q4 | $3.05M | Sell |
912,527
-114,860
| -11% | -$384K | ﹤0.01% | 915 |
|
|
2020
Q3 | $3.13M | Sell |
1,027,387
-624,824
| -38% | -$1.91M | 0.01% | 816 |
|
|
2020
Q2 | $7.63M | Buy |
1,652,211
+323,645
| +24% | +$1.5M | 0.01% | 612 |
|
|
2020
Q1 | $5.21M | Buy |
1,328,566
+974,809
| +276% | +$3.82M | 0.01% | 660 |
|
|
2019
Q4 | $1.33M | Buy |
+353,757
| New | +$1.33M | ﹤0.01% | 934 |
|